Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Amedisys Inc

AMED
Current price
97.75 USD -0.55 USD (-0.56%)
Last closed 97.58 USD
Sector Healthcare
Industry Medical Care Facilities
Exchange NASDAQ
Capitalization 3 189 265 408 USD
Yield for 12 month +8.80 %
1Y
3Y
5Y
10Y
15Y
AMED
21.11.2021 - 28.11.2021

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Address: 3854 American Way, Baton Rouge, LA, United States, 70816

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

97.78 USD

P/E ratio

Dividend Yield

Current Year

+2 236 382 000 USD

Last Year

+2 223 199 000 USD

Current Quarter

+571 414 000 USD

Last Quarter

+570 788 000 USD

Current Year

+457 077 000 USD

Last Year

+962 774 000 USD

Current Quarter

+117 660 000 USD

Last Quarter

+430 185 000 USD

Key Figures AMED

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 226 544 000 USD
Operating Margin TTM 9.15 %
PE Ratio
Return On Assets TTM 6.26 %
PEG Ratio 1.3512
Return On Equity TTM -1.87 %
Wall Street Target Price 97.78 USD
Revenue TTM 2 251 407 104 USD
Book Value 33.3 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 2.7 %
Dividend Yield
Gross Profit TTM 453 983 000 USD
Earnings per share -0.64 USD
Diluted Eps TTM -0.64 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -42.9 %
Profit Margin -0.92 %

Dividend Analytics AMED

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AMED

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 4:3
Payout Ratio
Last Split Date 05.12.2006
Dividend Date

Stock Valuation AMED

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 20.284
Enterprise Value Revenue 1.5037
Price Sales TTM 1.3424
Enterprise Value EBITDA 26.1218
Price Book MRQ 2.8149

Financials AMED

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AMED

For 52 weeks

89.55 USD 98.46 USD
50 Day MA 94.61 USD
Shares Short Prior Month 2 355 734
200 Day MA 93.59 USD
Short Ratio 7.19
Shares Short 2 307 830
Short Percent 7.18 %

Dynamics of changes in the value of assets

0

0R3Y

124.70 NOK Entra ASA 0 (0%)
Detailed analytics
G

GDRX

8.74 USD Goodrx Holdings Inc -0.21 (-2.35%)
Detailed analytics
S

SDV

22.31 EUR SAAB -B- -0.44 (-1.8%)
Detailed analytics
T

T14

2.39 USD TIANJIN PHARM DA REN TANG GRP -0.08 (-3.24%)
Detailed analytics
S

SUL1

95.55 EUR SULZER N 0 (0%)
Detailed analytics